GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2 | affects expression | EXP | | 6480464 | CTD | Thioacetamide affects the expression of BCL2 protein | PMID:21885874 PMID:34792689 | Bcl2 | increases expression | EXP | | 6480464 | CTD | Thioacetamide results in increased expression of BCL2 mRNA | PMID:29133031 PMID:30138605 | Bcl2 | multiple interactions | EXP | | 6480464 | CTD | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA; Berberine inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]; chloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]; chloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]; Doxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]; Doxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]; Quercetin inhibits the reaction [Thioacetamide affects the expression of BCL2 protein modified form]; S100B protein promotes the reaction [Thioacetamide results in decreased expression of BCL2 protein]; Thioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA] | PMID:21885874 PMID:23830814 PMID:29133031 PMID:30138605 PMID:34792689 | Bcl2 | multiple interactions | ISO | Bcl2 (Mus musculus) | 6480464 | CTD | [TXNIP gene mutant form co-treated with Thioacetamide] results in increased expression of BCL2 protein | PMID:20713078 | |
Go Back to source page | Continue to Ontology report |